Established in December 2000, MEDINFAR MAROCCO is currently among the first 60 pharmaceutical laboratories operating in Morocco’s pharmaceutical market.

MEDINFAR MAROCCO counts with a dynamic team, covering all the country’s main regions.

Morocco’s subsidiary offers to the Moroccan pharmaceutical market a range of quality products at competitive prices as other services. 

Thus, In close collaboration with its local manufacturing partners who comply with manufacturing international standards, MEDINFAR MAROCCO covers the following therapeutic areas:

• RHEUMATOLOGY and ANTI-INFLAMMATORY AREA:
  • Piroxicam;
  • Ibuprofen;
• GASTROENTEROLOGY AREA:
  • Omeprazole;
  • Domperidone; 
• CARDIOLOGY AREA:
  • Captopril;
• DERMATOLOGY AREA:
  • Isotretinoin;
  • Acyclovir;
  • Minoxidil; 
• ANTI-INFECTIOUS AREA: 
  • Acyclovir;
  • Minocycline;
• RESPIRATORY AREA:
  • Budesonide.